A detailed history of Nisa Investment Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 29,742 shares of REGN stock, worth $21.3 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
29,742
Previous 22,236 33.76%
Holding current value
$21.3 Million
Previous $23.4 Million 33.78%
% of portfolio
0.19%
Previous 0.15%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$1024.09 - $1201.76 $7.69 Million - $9.02 Million
7,506 Added 33.76%
29,742 $31.3 Million
Q2 2024

Jul 19, 2024

BUY
$883.2 - $1071.19 $695,961 - $844,097
788 Added 3.67%
22,236 $23.4 Million
Q1 2024

May 01, 2024

SELL
$902.69 - $993.35 $717,638 - $789,713
-795 Reduced 3.57%
21,448 $20.6 Million
Q4 2023

Jan 25, 2024

SELL
$775.18 - $881.7 $302,320 - $343,863
-390 Reduced 1.72%
22,243 $19.5 Million
Q3 2023

Nov 02, 2023

SELL
$692.45 - $844.37 $749,230 - $913,608
-1,082 Reduced 4.56%
22,633 $18.6 Million
Q2 2023

Aug 11, 2023

SELL
$700.03 - $830.35 $417,917 - $495,718
-597 Reduced 2.46%
23,715 $17 Million
Q1 2023

May 02, 2023

BUY
$680.49 - $826.97 $2.66 Million - $3.24 Million
3,913 Added 19.18%
24,312 $20 Million
Q4 2022

Feb 02, 2023

SELL
$705.89 - $766.39 $416,475 - $452,170
-590 Reduced 2.81%
20,399 $14.7 Million
Q3 2022

Nov 07, 2022

SELL
$573.97 - $724.32 $1.17 Million - $1.47 Million
-2,032 Reduced 8.83%
20,989 $14.5 Million
Q2 2022

Aug 03, 2022

BUY
$548.35 - $738.84 $1.37 Million - $1.84 Million
2,494 Added 12.15%
23,021 $13.6 Million
Q4 2021

Feb 03, 2022

SELL
$543.48 - $670.97 $1.26 Million - $1.55 Million
-2,315 Reduced 10.13%
20,527 $12.5 Million
Q3 2021

Oct 18, 2021

BUY
$574.03 - $680.96 $229,612 - $272,384
400 Added 1.78%
22,842 $13.8 Million
Q2 2021

Aug 06, 2021

BUY
$472.8 - $558.54 $1.06 Million - $1.26 Million
2,248 Added 11.13%
22,442 $12.5 Million
Q1 2021

Apr 26, 2021

SELL
$446.73 - $548.2 $507,038 - $622,207
-1,135 Reduced 5.32%
20,194 $9.56 Million
Q4 2020

Jan 25, 2021

SELL
$478.3 - $607.98 $880,072 - $1.12 Million
-1,840 Reduced 7.94%
21,329 $10.3 Million
Q3 2020

Oct 20, 2020

SELL
$544.75 - $658.21 $924,440 - $1.12 Million
-1,697 Reduced 6.82%
23,169 $13 Million
Q2 2020

Jul 27, 2020

SELL
$493.32 - $643.92 $2.56 Million - $3.34 Million
-5,191 Reduced 17.27%
24,866 $15.5 Million
Q1 2020

Apr 17, 2020

BUY
$336.18 - $494.43 $1.03 Million - $1.51 Million
3,060 Added 11.33%
30,057 $14.7 Million
Q4 2019

Jan 17, 2020

BUY
$274.13 - $376.51 $1.53 Million - $2.11 Million
5,597 Added 26.15%
26,997 $10.1 Million
Q3 2019

Oct 17, 2019

SELL
$273.46 - $318.39 $157,512 - $183,392
-576 Reduced 2.62%
21,400 $5.94 Million
Q2 2019

Jul 12, 2019

BUY
$299.6 - $414.82 $597,702 - $827,565
1,995 Added 9.98%
21,976 $6.88 Million
Q1 2019

Apr 17, 2019

SELL
$372.08 - $439.57 $520,912 - $615,398
-1,400 Reduced 6.55%
19,981 $8.21 Million
Q4 2018

Jan 17, 2019

SELL
$335.82 - $403.04 $87,649 - $105,193
-261 Reduced 1.21%
21,381 $7.99 Million
Q3 2018

Oct 16, 2018

BUY
$351.14 - $408.51 $1.09 Million - $1.27 Million
3,098 Added 16.71%
21,642 $8.74 Million
Q2 2018

Jul 19, 2018

SELL
$284.6 - $344.99 $2.44 Million - $2.96 Million
-8,577 Reduced 31.62%
18,544 $6.4 Million
Q1 2018

Apr 10, 2018

BUY
$315.82 - $393.78 $1.67 Million - $2.08 Million
5,286 Added 24.21%
27,121 $9.27 Million
Q4 2017

Jan 12, 2018

SELL
$358.63 - $469.95 $588,511 - $771,187
-1,641 Reduced 6.99%
21,835 $8.21 Million
Q3 2017

Oct 13, 2017

BUY
$431.38 - $504.0 $10.1 Million - $11.8 Million
23,476
23,476 $10.5 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.